62491-92-3

Usage

Uses

Used in Coordination Chemistry:
N-PYRIDIN-3-YLETHANE-1,2-DIAMINE is used as a ligand for the formation of coordination compounds. Its ability to chelate with metal ions makes it a valuable component in the synthesis of metal complexes with potential applications in various fields.
Used in Organic Synthesis:
In the realm of organic synthesis, N-PYRIDIN-3-YLETHANE-1,2-DIAMINE serves as a versatile building block. Its presence in various organic compounds allows for the creation of a wide range of chemical entities with diverse properties and potential applications.
Used in Pharmaceutical Industry:
N-PYRIDIN-3-YLETHANE-1,2-DIAMINE is utilized in the pharmaceutical industry as a precursor for the synthesis of potential drug candidates. Its unique structure and reactivity contribute to the development of new therapeutic agents with specific pharmacological properties.
Used in Chemical Research:
Due to its distinctive chemical structure, N-PYRIDIN-3-YLETHANE-1,2-DIAMINE is also employed in chemical research to explore new reactions, mechanisms, and the synthesis of novel compounds with potential applications in various industries.

InChI:InChI=1/C7H11N3/c8-3-5-10-7-2-1-4-9-6-7/h1-2,4,6,10H,3,5,8H2

Upstream product

• 462-08-8 pyridin-3-ylamine 
• 107-16-4 glycolonitrile 
• 626-55-1 3-Bromopyridine 
• 107-15-3 ethylenediamine 
• 626-60-8 3-Chloropyridine 

Downstream Products

• 1048675-00-8 2'-Chloro-5'-[5-methanesulfonyl-1-(3-pyrrolidin-1-yl-propyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-3-yl]-biphenyl-3-carboxylic acid [2-(pyridin-3-ylamino)-ethyl]-amide 

Relevant academic research and scientific papers

BIARYL-SUBSTITUTED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S

Biaryl-substituted tetrahydro-pyrazolo-pyridine compounds are described, which are useful as cathepsin S modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions media

SUBSTITUTED 2H-[1,2,4]TRIAZOLO[4,3-A]PYRAZINES AS GSK-3 INHIBITORS

The invention relates to compounds of formula (I) prodrugs thereof, and the pahrmaceutically acceptabel salts of the compounds and prodrugs, wherein Ra, Rb, R1 and R2 are as defined herein; pharmaceutical compositions thereof; and uses thereof.

Substituted 4-amino[1,2,4]triazolo[4,3-a] quinoxalines

The present invention provides compounds of formula (I) the prodrugs thereof, and the pharmaceutically acceptable salts of the compounds and prodrugs, wherein Ra, Rb, R1, and R2 are as defined herein; pharmaceutical compositions thereof; and uses thereof.

Pyridine derivative, anti-ulcer drug, and antibacterial drug

A pyridine derivative or a salt thereof expressed by the following formula 1: STR1 wherein W represents a group expressed by the following formula 2 or formula 3; STR2 wherein R1 represents an alkenyloxy group; n represents 1 or 2; Ra represents a lower alkyl group; and Rb represents a halogen atom; and wherein each of R2 and R3 represents a hydrogen atom, a lower alkyl group, a lower alkoxy group, or halogenated alkyl group; Y represents a group expressed by --S--, --NH-- or --CONH--; m represents an integer of 0 to 2; and p represents 0 or 1. The pyridine derivative has an anti-ulcer effect or an antibacterial activity against Helicobacter pyroli to be available for prevention or cure of ulcers.